Tag - BWV

Developments

Blue Water acquires 6 FDA-approve drugs across various indication

Blue Water Biotech (NASDAQ:BWV) signed asset purchase agreements with WraSer and Xspire Pharma to acquire six FDA-approved assets across multiple indications, including cardiology, otic infections, and pain management...

June 14, 2023

Developments

Blue Water Vaccines changes name to Blue Water Biotech

Blue Water Vaccines changed its corporate name to Blue Water Biotech, following its recent acquisition of ENTADFI, an FDA-approved treatment for benign prostatic hyperplasia, which has begun Blue Water’s transition into...

April 25, 2023

Markets

Maxim starts Blue Water Vaccines at buy; PT $4

Maxim Group initiated coverage of Blue Water Vaccines (NASDAQ:BWV) with a “buy” rating and price target of $4. The stock closed at $1.15 on Dec. 7. Blue Water is developing a portfolio of vaccine candidates targeting...

December 8, 2022

Feature

Blue Water Vaccines designing vaccines against infectious diseases

Blue Water Vaccines (NASDAQ:BWV) is building an early-stage pipeline of six transformational vaccine candidates targeting important infectious diseases, including inner ear infections, influenza, norovirus, rotavirus...

September 20, 2022

Developments

Blue Water to explore development of VLP monkeypox vaccine

Blue Water Vaccines (NASDAQ:BWV) plans to explore the potential to develop a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle (VLP) platform. The company’s shell and protrusion...

August 17, 2022

Developments

Blue Water Vaccines in $10-million private placement

Blue Water Vaccines (NASDAQ:BWV) entered into definitive agreements with several healthcare-focused institutional investors for the purchase of 3,683,280 common shares of the company in a private placement priced at-the...

August 9, 2022

Tag - BWV

Blue Water acquires 6 FDA-approve drugs across various indication

Blue Water Vaccines changes name to Blue Water Biotech

Maxim starts Blue Water Vaccines at buy; PT $4

Blue Water Vaccines designing vaccines against infectious diseases

Blue Water to explore development of VLP monkeypox vaccine

Blue Water Vaccines in $10-million private placement

General

More